MedPage Today | Cytokinetics, Inc. (CYTK): Cytokinetics: Presentation At Heart Failure Society ... Seeking Alpha Cytokinetics (CYTK) and Amgen (AMGN) first presented data from the ATOMIC HF trial at the European Society of Cardiology Congress (ESC) on September 2, 2013. This was a 48 hour dose ranging study in patients who were hospitalized with heart failure. MIs in ATOMIC-AHF Trial Pose No Problems |
